Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Osheru Receives Funding for Ziplyft Device for Blepharoplasty

Osheru announced the successful completion of a $4.7 million funding round aimed at accelerating the development and commercialization of its Ziplyft device for blepharoplasty surgery. The funding round was oversubscribed and led by a consortium of investors including individuals, family…

New Research Unveils Uveal Melanoma Metastasis Mechanisms

New research from Edith Cowan University (ECU) is shedding light on the factors driving the metastasis of uveal melanoma, the deadliest form of eye cancer known for its high rate of spreading to the liver. Uveal Melanoma Overview and Metastasis…

Samsara Vision Launches SING IMT in China

Samsara Vision announced the successful completion of the first SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) procedure in China. This milestone was achieved at the First Affiliated Hospital of Hainan Medical University Lecheng Hospital, where Professor Li Xiaorong, MD, PhD,…

Topcon and Orbis Partner to Expand DR Screening in Rwanda

Topcon Healthcare, in collaboration with Orbis International and the Rwanda International Institute of Ophthalmology (RIIO), has embarked on an initiative to enhance diabetic retinopathy screening in Rwanda. Donation of Robotic Retinal Cameras To facilitate this effort, Topcon has generously donated…

Trial Results for Susvimo Show Sustained Efficacy in DME and DR

Genentech and Roche released compelling 2-year data from the phase 3 Pagoda and Pavilion studies evaluating Susvimo (ranibizumab injection) 100 mg/mL, marking a significant development in the treatment landscape for diabetic macular edema (DME) and diabetic retinopathy (DR). Reintroduction of…

Stay informed and not overwhelmed, subscribe now!